HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Joris A M van der Post Selected Research

Tocolysis

5/2016Nifedipine versus atosiban for threatened preterm birth (APOSTEL III): a multicentre, randomised controlled trial.
1/2016Fetal fibronectin status and cervical length in women with threatened preterm labor and the effectiveness of maintenance tocolysis.
3/2015Impact of a randomized trial on maintenance tocolysis on length of hospital admission of women with threatened preterm labor in The Netherlands.
1/2015Pharmacokinetics of nifedipine slow-release during sustained tocolysis.
1/2013Effect of maintenance tocolysis with nifedipine in threatened preterm labor on perinatal outcomes: a randomized controlled trial.
9/2009Cost-effectiveness of fibronectin testing in a triage in women with threatened preterm labor: alleviation of pregnancy outcome by suspending tocolysis in early labor (APOSTEL-I trial).

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Joris A M van der Post Research Topics

Disease

10Premature Obstetric Labor (Premature Labor)
02/2017 - 09/2009
7Premature Birth (Birth, Premature)
07/2017 - 09/2009
7Pre-Eclampsia (Preeclampsia)
01/2015 - 08/2002
4Fetal Distress
09/2019 - 01/2010
3Fetal Growth Retardation (Intrauterine Growth Retardation)
01/2019 - 04/2012
3Habitual Abortion (Recurrent Miscarriage)
01/2016 - 04/2010
2Hyperemesis Gravidarum
01/2021 - 01/2016
2Uterine Hemorrhage (Uterine Bleeding)
02/2017 - 10/2015
1Autoimmune Diseases (Autoimmune Disease)
01/2022
1Thyroid Diseases (Thyroid Disease)
01/2022
1Antiphospholipid Syndrome (Antiphospholipid Antibody Syndrome)
01/2022
1Disease Progression
01/2021
1Rupture
09/2019
1Seizures (Absence Seizure)
01/2019
1Epilepsy (Aura)
01/2019
1Meconium Aspiration Syndrome
11/2018
1Tics (Tic)
01/2018
1Breech Presentation
04/2016
1Dehydration (Water Stress)
01/2016
1Malnutrition (Nutritional Deficiencies)
01/2016
1Vomiting
01/2016
1Nausea
01/2016
1Gestational Weight Gain
01/2016
1Birth Weight (Birth Weights)
01/2016
1Preterm Premature Rupture of the Membranes
10/2015
1Body Weight (Weight, Body)
01/2015
1Hypoxia (Hypoxemia)
01/2015
1Weight Gain
10/2014
1Perinatal Death
01/2014
1Intrahepatic Cholestasis of Pregnancy
01/2014
1progressive familial intrahepatic 3 Cholestasis
01/2014
1Pruritus (Itching)
01/2014
1Stillbirth
04/2012
1Uterine Perforation
12/2011
1Uterine Rupture
12/2011
1Hypothyroidism
09/2011
1Infertility (Sterility)
09/2011
1Postpartum Thyroiditis (Thyroiditis, Postpartum)
09/2011
1Spontaneous Abortion (Miscarriage)
09/2011
1Venous Thrombosis (Deep-Vein Thrombosis)
01/2011
1Hemorrhage
01/2011
1HELLP Syndrome
01/2011
1Mental Fatigue
12/2010
1Neoplasms (Cancer)
11/2010
1Teratogenesis
12/2009
1Hypercholesterolemia
12/2009

Drug/Important Bio-Agent (IBA)

8Fibronectins (Fibronectin)IBA
02/2017 - 09/2009
6Adrenal Cortex Hormones (Corticosteroids)IBA
05/2016 - 09/2009
5Oxytocin (Pitocin)FDA LinkGeneric
09/2019 - 01/2010
4Nifedipine (Adalat)FDA LinkGeneric
05/2016 - 01/2013
3Thyroxine (Levothyroxine)FDA LinkGeneric
01/2022 - 04/2016
3AntibodiesIBA
01/2022 - 09/2011
2Thyrotropin (Thyroid-Stimulating Hormone)FDA Link
01/2021 - 04/2016
2Pharmaceutical PreparationsIBA
09/2019 - 01/2011
2Aspirin (Acetylsalicylic Acid)FDA LinkGeneric
07/2017 - 04/2010
2RNA (Ribonucleic Acid)IBA
01/2015 - 06/2006
2Low-Molecular-Weight Heparin (Heparin, Low Molecular Weight)IBA
01/2011 - 04/2010
1Immunoglobulin G (IgG)IBA
01/2022
1Lupus Coagulation Inhibitor (Lupus Anticoagulant)IBA
01/2022
1Immunoglobulin M (IgM)IBA
01/2022
1Glycoproteins (Glycoprotein)IBA
01/2022
1Anticonvulsants (Antiepileptic Drugs)IBA
01/2019
1Levetiracetam (Keppra)FDA LinkGeneric
01/2019
1Lamotrigine (Lamictal)FDA LinkGeneric
01/2019
1UK-4IBA
01/2019
1Soaps (Soap)IBA
02/2017
1atosibanIBA
05/2016
1Calcium Channel Blockers (Blockers, Calcium Channel)IBA
05/2016
1Iodide Peroxidase (Deiodinase)IBA
01/2016
1ElementsIBA
01/2015
1Biomarkers (Surrogate Marker)IBA
01/2015
1TabletsIBA
01/2015
1Glucose (Dextrose)FDA LinkGeneric
10/2014
1Triglycerides (Triacylglycerol)IBA
10/2014
1Bile Acids and Salts (Bile Acids)IBA
01/2014
1DNA (Deoxyribonucleic Acid)IBA
01/2014
1Rifampin (Rifampicin)FDA LinkGeneric
01/2014
1Ursodeoxycholic Acid (Urso)FDA LinkGeneric
01/2014
1Proteins (Proteins, Gene)FDA Link
01/2013
1preemptIBA
04/2012
1ProstaglandinsIBA
12/2011
1GlucocorticoidsIBA
01/2011
1Cytostatic AgentsIBA
11/2010
1Nadroparin (Nadroparin Calcium)IBA
04/2010
1Heparin (Liquaemin)FDA LinkGeneric
04/2010
1CholesterolIBA
12/2009
1Hydroxymethylglutaryl-CoA Reductase Inhibitors (HMG-CoA Reductase Inhibitors)IBA
12/2009

Therapy/Procedure

6Tocolysis
05/2016 - 09/2009
3Induced Labor
01/2019 - 04/2012
2Cesarean Section (Caesarean Section)
09/2019 - 11/2018
2Length of Stay
01/2016 - 12/2010
1Contraindications
01/2022
1Catheters
01/2018
1Indwelling Catheters (Indwelling Catheter)
01/2018
1Aftercare (After-Treatment)
01/2016
1Enteral Nutrition (Feeding, Tube)
01/2016
1Epidural Analgesia
01/2016
1Episiotomy
01/2016
1Therapeutics
01/2015
1Neonatal Intensive Care
01/2014